The development and implementation of novel methods for the diagnosis and monitoring of leukemia and lymphoma has been the focus of my efforts for the past 25 years. This has resulted in the development of new technology and assays in the fields of flow cytometry and next generation sequencing that have garnered international recognition. As a result, I have extensive experience in the delivery of laboratory testing to support large clinical trials in the field of oncology and have provided services for large cooperative oncology groups trials and contract testing for biopharma companies.